EQUASENS |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 58 EUR | -2.52% |
|
-0.17% | -5.07% |
| Apr. 02 | Equasens : RNPG virtually stable in 2023 | CF |
| Mar. 29 | Equasens Société Anonyme Provides Revenue Guidance for the 2025 | CI |
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
Weaknesses
- The company's earnings growth outlook lacks momentum and is a weakness.
- The company's enterprise value to sales, at 3.75 times its current sales, is high.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
Ratings chart - Surperformance
Sector: IT Services & Consulting
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -5.07% | 931M | - | ||
| -12.23% | 194B | A- | ||
| +0.74% | 166B | B+ | ||
| +2.19% | 153B | B- | ||
| +4.34% | 99.85B | A- | ||
| +7.04% | 77.56B | A- | ||
| +19.09% | 73.55B | C- | ||
| -7.30% | 71B | A | ||
| -20.54% | 52.81B | C | ||
| +0.53% | 47.86B | A- |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- EQS Stock
- Ratings Equasens
